Competitor Analysis c-Met/HGF Inhibitors

  • February 2010
  • -
  • La Merie Publishing

Product description

The Competitive Intelligence Report c-MET/HGF Inhibitors as of February 2010 provides a competitor analysis in the development pipeline of novel emerging inhibitors of c-MET receptor tyrosine kinase (RTK) and its ligand hepatocyte growth factor (HGF) or scatter factor (SF) for treatment of solid tumors. Most of the inhibitors are small molecules, but antibodies are a strongly emerging class of c-Met/HGF antagonists.

The c-MET signalling pathway consists of the mesenchymal epithelial transition factor (c-MET) transmembrane tyrosine kinase receptor and its ligand hepatocyte growth factor (HGF) or scatter factor (SF). Binding of HGF/SF to c-MET activates downstream signalling pathways such as Rho, focal adhesion kinase (FAK) and PI3K. These pathways regulate cancer cell growth, survival angiogenesis, invasion and metastasis. Thus, prevention of c-MET dependent neoplastic processes may provide a means for managing invasive tumors of high metastatic potential. In fact, c-MET/HGF has evolved as an attractive target for the pharmaceutical industry.

At present, at least 16 different molecules including four antibodies are in clinical development and quite a number of projects are in preclinical development. The majority of approaches are directed at inhibiting the c-MET receptor tyrosine kinsase (RTK) by small molecules. The first generation of c-MET RTK inhibitors are dual- or multi-targeting c-MET inhibitors. These multi-target c-MET inhibitors are most advanced in clinical development with two projects in phase III. The next wave of c-MET inhibitors typically are ATP-competitive potent and highly selective c-MET inhibitors with lead compounds in phase II.

The Competitor Analysis c-MET/HGF Inhibitors also provides the corporate R&D pipelines for c-MET/HGF Inhibitors. The report includes a compilation of current active projects in research and development of c-Met/HGF Inhibitors. Competitor projects are listed in a tabular format providing Information on:

* Drug Codes,
* Target / Mechanism of Action,
* Class of Compound,
* Company,
* Product category,
* Indication,
* R&D Stage and
* additional comments with a hyperlink leading to the source of information.

Index

* Selective c-MET/HGF Inhibitors
* Dual- and Multi-Targeting c-MET/HGF Inhibitors
* C-Met/HGF Inhibitory Antibodies

Table Of Contents

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global CRO Market : Transformation, Developments, Opportunities and Future of CRO Market

Global CRO Market : Transformation, Developments, Opportunities and Future of CRO Market

  • $ 10 000
  • Industry report
  • February 2015
  • by Frost & Sullivan

Key Findings •The global Contract Research Organization (CRO) market was $ x billion in 2014 and is expected to reach $ x billion in 2019, growing at a robust CAGR (2014-2019) of x %. •The penetration ...

Proteomics: Technologies and Global Markets

Proteomics: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019. ...

Drug Discovery Technologies, BCC Research

Drug Discovery Technologies, BCC Research

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.